Related Experiment Video
Updated: Jul 16, 2026

Preoxygenation Techniques for Tracheal Intubation in Critically Ill Adults Utilizing Oxygen Mask and Noninvasive Ventilation
Published on: December 5, 2025
Evidence-based use of adjunctive therapies to ventilation
Thomas E Wiswell1, Win Tin, Kirsten Ohler
1Center for Neonatal Care, Florida Hospital Orlando, 2718 North Orange Avenue, Suite B, Orlando, FL 32804, USA. thomas_wiswell@yahoo.com
Insights
This review examines adjunctive therapies for common neonatal lung diseases, including respiratory distress syndrome and bronchopulmonary dysplasia. It evaluates the evidence supporting or refuting their use in newborn intensive care units.
Area of Science:
- Neonatology
- Pulmonology
- Pediatric critical care
Background:
- Respiratory distress is a leading cause for neonatal intensive care unit admissions.
- Neonatal pulmonary disorders significantly impact infant health outcomes.
- Therapeutic strategies for neonates with lung disease have evolved substantially.
Purpose of the Study:
- To review and synthesize the evidence for adjunctive therapies in neonatal lung diseases.
- To assess the efficacy and safety of various treatment modalities.
- To provide an evidence-based overview for clinicians managing these conditions.
Main Methods:
- Systematic review of existing literature.
- Analysis of clinical trials and observational studies.
- Evidence appraisal for specific neonatal pulmonary conditions.
Main Results:
- Evidence varies significantly across different adjunctive therapies and neonatal lung conditions.
- Some therapies show promise in mitigating disease course, while others lack robust support.
- Specific recommendations are discussed for respiratory distress syndrome, bronchopulmonary dysplasia, and other disorders.
Conclusions:
- Adjunctive therapies play a role in managing neonatal lung disease, but their application requires careful consideration of evidence.
- Further research is needed to establish definitive guidelines for certain treatments.
- Optimizing treatment strategies can improve outcomes for neonates with respiratory disorders.
Abstract:
Respiratory distress is the most common reason for admission to newborn intensive care units. Over the past two decades, we have witnessed a revolution in the therapies that are used to manage neonates who have pulmonary disorders. Multiple adjunctive agents have also been used in an attempt to mitigate the course of neonatal lung disease. The disorders we discuss include respiratory distress syndrome, chronic lung disease/bronchopulmonary dysplasia, persistent pulmonary hypertension of the newborn, meconium aspiration syndrome, and transient tachypnea of the newborn. We review the evidence that either supports or refutes the use of adjunctive therapies for these disorders.
Related Concept Videos
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Heart Failure VI: Adjunct Therapies
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation (NIPPV)
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Mechanical Ventilation I: Indication and Settings
COPD: Management Using Bronchodilators and Corticosteroids
